Journal of Chemotherapy

Papers
(The median citation count of Journal of Chemotherapy is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients24
The tumor microenvironment: shaping cancer progression and treatment response19
Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes16
Mechanisms underlying dose-limiting toxicities of conventional chemotherapeutic agents14
Piperacillin/Tazobactam is associated with a higher risk of acute kidney injury compared to cefepime and meropenem14
Clinical benefit of anti-PD-1/PD-L1 plus chemotherapy in first-line treatment for patients over the age of 65 or 75 with metastatic non-small cell lung cancer (NSCLC)12
Factors associated with immune-related thyroid dysfunction induced by PD-1/PD-L1 inhibitors in cancer patients: an observational study12
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital11
Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study11
Underutilisation of prophylactic G-CSF in breast cancer patients receiving adjuvant docetaxel/cyclophosphamide chemotherapy10
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA210
Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis10
Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine10
Improving therapeutic resistance: beginning with targeting the tumor microenvironment10
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer10
Class 1, 2 and 3 integrons in clinical Pseudomonas aeruginosa isolated from Tanta University Hospitals, Egypt10
Development and validation of a clinical risk score nomogram for predicting voriconazole trough concentration above 5 mg/L: a retrospective cohort study9
Management of hereditary hemorrhagic telangiectasia-like symptoms induced by trastuzumab emtansine in a breast cancer patient: case report9
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae9
Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring9
Novel daidzein molecules exhibited anti-prostate cancer activity through nuclear receptor ERβ modulation, in vitro and in vivo studies9
Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet9
Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study9
Adjuvant chemotherapy for elderly patients with colorectal cancer: a single-centre observational study in Japan8
Effectiveness and safety of a disposable elastomeric continuous infusion pump for outpatient parenteral antimicrobial therapy (OPAT) in a UK setting8
Fixed-dose antiretroviral combinations in children living with human immunodeficiency virus type 1 (HIV-1): a systematic review8
Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultations8
Sorafenib tosylate-loaded nanosuspension: preparation, optimization, and in vitro cytotoxicity study against human HepG2 carcinoma cells8
Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance P8
Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer8
Irreversible Cabozantinib-induced left ventricular systolic dysfunction, a potentially novel observation7
Efflux pump effects on Mycobacterium tuberculosis drug resistance7
Rapid health technology assessment of the novel endonuclease inhibitor baloxavir for the treatment of influenza7
The use of antiviral drugs in children7
Establishing and characterizing a novel doxorubicin-resistant acute myeloid leukaemia cell line6
Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam6
Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience6
Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database6
Infective endocarditis by Actinomyces species: a systematic review6
Bendamustine plus Rituximab versus R-miniCHOP: which is better for unfit patients with diffuse larger B-cell lymphoma?6
Combination of metronomic capecitabine and letrozole in metastatic hormone receptor positive, HER2 negative breast cancer: a randomized phase II trial6
The efficacy of lapatinib in patients with metastatic HER2 positive breast cancer who received prior therapy with monoclonal antibodies and antibody-drug conjugate: a single institutional experience6
Prognostic significance of pyrimidine metabolism-related genes as risk biomarkers in hepatocellular carcinoma6
Carbapenem-resistant Gram-negative pathogens associated with septic shock: a review of 120 cases6
Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin6
Neurological toxicities with poly (ADP-ribose) polymerase inhibitors in cancer patients: a systematic review and meta-analysis5
Comparison of venetoclax and ivosidenib/enasidenib for unfit newly diagnosed patients with acute myeloid leukemia and IDH1/2 mutation: a network meta-analysis5
Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced 5
Impact of antibiotic susceptibility reporting on broad spectrum antibiotic use in serratia and morganella bacteremia5
Long-term outcomes of sequential chemotherapy in epithelioid sarcoma5
Osimertinib and chemotherapy combination to treat brain metastasis flare and osimertinib resistance by EGFR C797S5
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis5
Real-world outcomes of metastatic clear cell sarcoma sequential chemotherapy5
Optimizing the dosing regimens of linezolid against gram-positive cocci in critically ill patients with different renal functions: a Monte Carlo simulation5
Assessment of micafungin dosage regimens against Candida spp. in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic/pharmacodynamic5
MiR-144-3p inhibits the proliferation, migration and invasion of lung adenocargen cancer cells by targeting COL11A15
Ultrastructural and immunohistochemical insights on the anti-glioma effects of a dual-drug cocktail in an in vivo experimental model4
YAP/TAZ axis was involved in the effects of metformin on breast cancer4
Retrospective analysis of risk factors for levofloxacin-induced liver injury4
Statement of Retraction: Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line4
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases4
Causative agents of bloodstream infections in two Croatian hospitals and their resistance mechanisms4
Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use4
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing4
Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapy4
Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey4
The point prevalence and inappropriateness of antibiotic use at hospitals in Turkey: a systematic review and meta-analysis4
Comparison of the prognostic effect of pyrotinib plus trastuzumab and chemotherapy different lines therapy in HER2-positive advanced breast cancer4
The acceleration of cisplatin resistance in colorectal cancer by lncRNA NORAD through regulation of miR-106a-5p/Cyclin D1 axis4
Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women – A systematic review and meta-analysis4
Depletion of circPDSS1 inhibits ITGA11 production to confer cisplatin sensitivity through miR-515-5p in gastric cancer4
Infective endocarditis by Serratia species: a systematic review4
Luteolin suppresses lung cancer progression through targeting the circ_0000190/miR-130a-3p/notch-1 signaling pathway4
Correction4
Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: a real-life study4
The BioWipe: a non-invasive method to detect intestinal carriage of multi-drug resistant GRAM-negative bacteria4
Transcriptional factor KLF9 overcomes 5-fluorouracil resistance in breast cancer via PTEN-dependent regulation of aerobic glycolysis4
Linezolid-related adverse effects in the treatment of rifampicin resistant tuberculosis: a retrospective study3
Intraventricular treatment of paediatric meningitis due to extensively drug-resistant Gram-negative bacteria: two case reports and review of the literature3
Emergency department care of ABSSSI with dalbavancin infusion, direct discharge, and outpatient telemedicine follow up: a study protocol3
Lambert-Eaton myasthenic syndrome (LEMS) in a patient with lung cancer under treatment with pembrolizumab: a case study3
Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin3
Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder cancer: tips and tricks for better efficacy and tolerability3
Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus in neutropenic patients with cancer by Monte Carlo simul3
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology 3
Performance of capecitabine in novel combination therapies in colorectal cancer3
Anti-programmed death ligand 1 immunotherapy in patients with limited-stage small cell lung cancer: a real-world exploratory study3
A cost minimisation analysis comparing oral linezolid and intravenous daptomycin administered via an outpatient parenteral antibiotic therapy programme in patients requiring prolonged antibiotic cours3
Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells3
Current status of systemic therapy in head and neck cancer3
Comparison of bamlanivimab with or without etesevimab and casirivimab-imdevimab in clinical outcomes in patients with COVID-19: a systematic review and meta-analysis3
Oral step-down therapy in patients with uncomplicated Staphylococcus aureus primary bacteremia and catheter-related bloodstream infections3
In-vitro activity of fosfomycin against Escherichia coli and Klebsiella pneumoniae bloodstream isolates and frequency of OXA-48, NDM, KPC, VIM, IMP types of carbapenemases 3
RANK pathway in cancer: underlying resistance and therapeutic approaches3
Disseminated fusariosis in immunocompromised children: a case series and review of literature3
Reevaluating immunotherapy’s potential in first-line metastatic urothelial carcinoma3
Evaluating omadacycline dosing regimens against drug-resistant pathogens including Staphylococcus aureus , Streptococcus pneumoniae and 3
In vitro activity of newer β-lactam/β-lactamase inhibitor combinations, cefiderocol, plazomicin and comparators against carbapenemase-producing Klebsiella pneumoniae<3
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019–2023
Rs3802278 in 3’-UTR ofSULF1associated with platinum resistance and survival in Chinese epithelial ovarian cancer patients3
Macrolides impact the growth ability of clinical Pseudomonas aeruginosa through quorum-sensing systems2
Pediatric impetigo: an expert panel opinion about its main controversies2
Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation2
Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection2
Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer2
Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics2
Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer2
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma2
Reversible chemoresistance of pancreatic cancer grown as spheroids2
MTHFR polymorphism as a predictive biomarker for gastrointestinal and hematological toxicity in North Indian adenocarcinoma patients2
Meta-analysis of echinocandins combined with trimethoprim-sulfamethoxazole for treatment of Pneumocystis pneumonia2
Are there differences between ceftolozane/tazobactam and ceftazidime/avibactam in treating patients with complicated abdominal infections? Evidence from clinical trials2
Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment2
Combined impact of hypoalbuminemia and pharmacogenomic variants on voriconazole trough concentration: data from a real-life clinical setting in the Chinese population2
DPYDandTYMSpolymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients2
Upregulation of apoptotic genes and downregulation of target genes of Sonic Hedgehog signaling pathway in DAOY medulloblastoma cell line treated with arsenic trioxide2
Intraperitoneal daptomycin dosing for peritonitis may be inadequate: a Monte Carlo simulation approach to optimize dosing and outcomes2
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma2
The pharmacokinetics of ganciclovir during prolonged intermittent kidney replacement therapy in a cardiac transplant recipient2
Comparison of lorlatinib, alectinib and brigatinib in ALK inhibitor–naive/untreated ALK-positive advanced non-small-cell lung cancer: a systematic review and network meta-analysis2
Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor origins2
MAP7 promotes proliferation and migration of breast cancer cells and reduces the sensitivity of breast cancer cells to paclitaxel2
Amikacin treatment in urinary tract infection patients: evaluating the risk of acute kidney injury – a retrospective cohort study2
Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy2
Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report2
Amikacin-induced acute kidney injury in mechanically ventilated critically ill patients with sepsis1
miR-302a-3p suppresses melanoma cell progression via targeting METTL31
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry1
Study on the clinical efficacy of 14-day vonoprazan-based triple regimen in obese patients with Helicobacter pylori infection1
Efficacy and safety of pembrolizumab for treating advanced non-small-cell lung cancer: a meta-analysis of phase II and III randomized controlled trials1
Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapy1
PD-1 inhibitors plus chemotherapy as first-line therapy for stage IV ESCC1
Evaluation of the post-antibiotic effectin vivofor the combination of a β-lactam antibiotic and a β-lactamase inhibitor: ceftazidime-avibactam in neutropenic mouse thigh and lung infections1
The crucial relationship between vancomycin minimum inhibitory concentration and therapeutic efficacy against methicillin-resistant coagulase-negative staphylococci1
Examining cardiac toxicity in HER2-positive breast cancer patients using trastuzumab and its influencing factors at Iran Hospital1
Systematic review and meta-analysis of the predictive power of MTHFR polymorphisms for pemetrexed drug efficacy and toxicity in non-small cell lung cancer patients1
Efficacy and safety of anlotinib as maintenance therapy in patients with advanced non-small cell lung cancer achieving SD post first-line chemotherapy combined with immunotherapy1
Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort1
The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta-analysis1
Oral fosfomycin for treating lower urinary tract infections due to multidrug-resistant Escherichia coli in female adolescents1
MPO-ANCA positive glomerulonephritis during PD-1 inhibitor combined with anti-CTLA4 antibody in lung cancer1
Clinical value of circulating tumour cells in evaluating the efficacy of continuous hepatic arterial infusion among colorectal cancer patients1
Conceptual framework of antibiotic stewardship programs in reducing ESBL-producing Enterobacteriaceae: a systematic review and meta-analysis1
Evaluation of in vitro activity of ceftaroline, ceftobiprole and their combination with trimethoprim/sulfamethoxazole against MRSA isolates: a two center study1
Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia1
Risk factors of poor nutrition in non-small cell lung cancer patients after chemotherapy: cross-sectional study1
Relationship between the change in tumour-infiltrating lymphocyte level and residual tumour after neoadjuvant chemotherapy in patients with locally advanced breast cancer1
Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation1
Tumor mutational burden in non-immunotherapy patients with heavily pretreated metastatic breast cancer: long-term outcomes from a single institution1
microRNA-143 interferes the EGFR-stimulated glucose metabolism to re-sensitize 5-FU resistant colon cancer cells via targeting hexokinase 21
Characteristics and predictors of infusion-related reactions to rituximab in patients with B-cell non-Hodgkin lymphoma1
Does discontinuing bleomycin due to toxicity increase the risk of lymphoma progression? Real-life data from a homogeneous population of advanced stage Hodgkin lymphoma1
The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study1
Infective endocarditis byKlebsiellaspecies: a systematic review1
Comparative efficacy of chemo-immunotherapy combination regimens in the frontline setting for NSCLC based on reconstructed patient data1
Successful treatment of postsurgical meningitis caused by Bacillus cereus : a case report and literature review1
Astaxanthin induces autophagy and apoptosis in murine melanoma B16F10-Nex2 cells and exhibits antitumor activity in vivo1
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy increases carotid intima-media thickness and plaque score with von Willebrand factor activity elevation in pati1
Aminoglycoside antibiotics as first-line treatment of acute appendicitis and cholecystitis1
Urinary tract infection in a human male patient with Staphylococcus pseudintermedius transmission from the family dog1
Prior immune checkpoint inhibitors may enhance severe hypersensitivity related to selpercatinib in RET fusion gene-positive lung cancer1
Self-assembled redox-responsive BRD4 siRNA nanoparticles: fomulation and its in vitro delivery in gastric cancer cells1
Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX21
Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience1
Effect of HDAC9 inhibition on epithelial-mesenchymal transition in CD133+ prostate cancer cell lines1
Mechanisms and applications of ferroptosis-associated regulators in cancer therapy and drug resistance1
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer1
Developing new drugs for adult T-cell leukemia/lymphoma by targeting hypoxia: insights from toxicity of MS-275 and its analogs1
In-vitro activity of plazomicin, meropenem-vaborbactam, and omadacycline against carbapenem-resistant Gram-negative isolates in Egypt1
Durable pembrolizumab response in metastatic MSS ARID1A-mutant undifferentiated carcinoma of the esophagus1
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey1
The relationship between statin administration timing and survival outcomes in patients with cancer receiving immune checkpoint blockade1
Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review1
Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer1
Comparisons of effects of SOX and mFOLFOX6 chemotherapy regimens on patients with locally advanced gastric cancer1
Predictors of olaparib discontinuation owing to adverse drug events in patients with ovarian, peritoneal, or fallopian tube cancer: a retrospective observational study1
Colistin resistance among the Gram-negative nosocomial pathogens in India: a systematic review and meta-analysis1
Identification of T cell-related biomarkers for breast cancer based on weighted gene co-expression network analysis1
LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis1
Anti-biofilm activity of dalbavancin against methicillin-resistant Staphylococcus aureus (MRSA) isolated from human bone infection1
Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients1
Overexpression of long non-coding RNA urothelial carcinoma associated 1 causes paclitaxel (Taxol) resistance in colorectal cancer cells by promoting glycolysis1
Assessment of in vitro interactions between delafloxacin and other antimicrobials against multi-drug resistant Pseudomonas aeruginosa strains1
A novel polymerase β inhibitor from phage displayed peptide library augments the anti-tumour effects of temozolomide on colorectal cancer1
Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK21
0.053412914276123